NTCM
IRMD icon

Nine Ten Capital Management’s iRadimed IRMD Stock Holding History

Nine Ten Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$24.5M Sell
256,562
-77,926
-23% -$7.1M 7.63% 6
2026
Q1 		$32.2M Sell
334,488
-93,989
-22% -$9.4M 10.23% 7
2025
Q4 		$41.7M Sell
428,477
-342,907
-44% -$29.4M 13.2% 5
2025
Q3 		$54.9M Sell
771,384
-100,619
-12% -$6.7M 14.15% 2
2025
Q2 		$52.1M Hold
872,003
– – 15.51% 2
2025
Q1 		$45.8M Sell
872,003
-33,923
-4% -$1.91M 17.08% 1
2024
Q4 		$49.8M Hold
905,926
– – 14.22% 2
2024
Q3 		$45.6M Buy
905,926
+28,124
+3% +$1.3M 13.77% 2
2024
Q2 		$38.6M Buy
877,802
+68,436
+8% +$2.91M 14.85% 2
2024
Q1 		$35.6M Buy
809,366
+10,000
+1% +$442K 10.84% 5
2023
Q4 		$37.9M Buy
799,366
+28,055
+4% +$1.18M 9.54% 4
2023
Q3 		$34.2M Sell
771,311
-11,755
-2% -$546K 10.44% 4
2023
Q2 		$37.4M Hold
783,066
– – 12.55% 4
2023
Q1 		$30.8M Buy
783,066
+1,300
+0.2% +$47.2K 5.13% 8
2022
Q4 		$22.1M Buy
781,766
+55,889
+8% +$1.6M 3.84% 8
2022
Q3 		$21.8M Hold
725,877
– – 3.33% 8
2022
Q2 		$24.6M Buy
725,877
+10,000
+1% +$358K 3.42% 8
2022
Q1 		$32.1M Sell
715,877
-14,782
-2% -$684K 4.18% 7
2021
Q4 		$33.8M Sell
730,659
-30,960
-4% -$1.25M 3.51% 10
2021
Q3 		$25.6M Hold
761,619
– – 2.74% 10
2021
Q2 		$22.4M Hold
761,619
– – 2.41% 10
2021
Q1 		$19.6M Buy
761,619
+97,850
+15% +$2.34M 2.72% 10
2020
Q4 		$15.1M Buy
663,769
+114,605
+21% +$2.65M 2.28% 9
2020
Q3 		$11.7M Buy
549,164
+133,268
+32% +$2.99M 2.44% 9
2020
Q2 		$9.65M Buy
415,896
+138,808
+50% +$2.98M 2.42% 8
2020
Q1 		$5.92M Buy
277,088
+146,816
+113% +$3.5M 2.51% 9
2019
Q4 		$3.05M Buy
130,272
+107,193
+464% +$2.5M 0.76% 10
2019
Q3 		$485K Buy
+23,079
New +$471K 0.15% 9

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Nine Ten Capital Management's IRMD Position: Q2 2026 in Review

Nine Ten Capital Management reduced its iRadimed (IRMD) stake by 23% in Q2 2026, selling an estimated $7.1M and leaving 256,562 shares worth $24.5M. The position accounts for 7.63% of the portfolio, ranked #6.

Nine Ten Capital Management first reported a position in IRMD in Q3 2019 and has held it in 28 quarters since. The position peaked at $54.9M in Q3 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Nine Ten Capital Management held 256,562 shares of iRadimed worth $24.5M as of Q2 2026.
  • Nine Ten Capital Management sold 77,926 iRadimed shares in Q2 2026, an estimated $7.1M.
  • iRadimed made up 7.63% of Nine Ten Capital Management's portfolio in Q2 2026, its #6 holding.
  • Nine Ten Capital Management first reported a position in iRadimed in Q3 2019 and has held it in 28 quarters since.
  • Nine Ten Capital Management's iRadimed position peaked at $54.9M in Q3 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Nine Ten Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.